Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

826 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial.
Blanco I, Santos S, Gea J, Güell R, Torres F, Gimeno-Santos E, Rodriguez DA, Vilaró J, Gómez B, Roca J, Barberà JA. Blanco I, et al. Among authors: gomez b. Eur Respir J. 2013 Oct;42(4):982-92. doi: 10.1183/09031936.00176312. Epub 2013 Feb 21. Eur Respir J. 2013. PMID: 23429918 Free article. Clinical Trial.
FRAGILE-COLCOVID19: A Clinical Trial Based on Early Administration of an Oral Combination of Colchicine and Prednisone in Elderly Patients with COVID-19 in Geriatric Facilities.
Hernández-Rodríguez J, Durán-Sanclemente J, Prieto-González S, Araújo O, Hospital-Vidal T, Casanovas G, Sapena V, Blanco JL, López-Soto A; FRAGILE-COLCOVID19 Study Group. Hernández-Rodríguez J, et al. Clin Drug Investig. 2022 Nov;42(11):949-964. doi: 10.1007/s40261-022-01201-2. Epub 2022 Sep 29. Clin Drug Investig. 2022. PMID: 36173596 Free PMC article. Clinical Trial.
Evaluation of a combined strategy directed towards health-care professionals and patients with chronic obstructive pulmonary disease (COPD): information and health education feedback for improving clinical monitoring and quality-of-life.
Valero C, Monteagudo M, Llagostera M, Bayona X, Granollers S, Acedo M, Ferro JJ, Rodríguez-Latre L, Almeda J, Muñoz L; COPD Group of SAP Baix LLobregat Centre. Valero C, et al. BMC Public Health. 2009 Dec 1;9:442. doi: 10.1186/1471-2458-9-442. BMC Public Health. 2009. PMID: 20128887 Free PMC article. Clinical Trial.
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.
Borobia AM, Carcas AJ, Pérez-Olmeda M, Castaño L, Bertran MJ, García-Pérez J, Campins M, Portolés A, González-Pérez M, García Morales MT, Arana-Arri E, Aldea M, Díez-Fuertes F, Fuentes I, Ascaso A, Lora D, Imaz-Ayo N, Barón-Mira LE, Agustí A, Pérez-Ingidua C, Gómez de la Cámara A, Arribas JR, Ochando J, Alcamí J, Belda-Iniesta C, Frías J; CombiVacS Study Group. Borobia AM, et al. Lancet. 2021 Jul 10;398(10295):121-130. doi: 10.1016/S0140-6736(21)01420-3. Epub 2021 Jun 25. Lancet. 2021. PMID: 34181880 Free PMC article. Clinical Trial.
Invasive bacterial infections in febrile infants younger than 3 months old after SARS-CoV-2 pandemic.
Bizkarra-Txurruka L, Lejarzegi A, Andina D, Gomez B, Mintegi S; el Grupo de Estudio de Calidad del manejo del lactante febril de la Red de Investigación de la Sociedad Española de Urgencias de Pediatría (RISEUP-SPERG). Bizkarra-Txurruka L, et al. Among authors: gomez b. An Pediatr (Engl Ed). 2025 Jan 6:503710. doi: 10.1016/j.anpede.2024.503710. Online ahead of print. An Pediatr (Engl Ed). 2025. PMID: 39762125 Free article. No abstract available.
826 results